Connect to other sites within the UBM Medica Network
Adoption of Hypofractionated Radiotherapy in Early-Stage Breast Cancer
The benefit of hypofractionated radiotherapy for women receiving breast-conserving therapy for early-stage breast cancer is becoming more apparent.
Socioeconomic Factors Affecting Use of Radiation Therapy in Hodgkin Lymphoma
Socioeconomic factors are reducing the use of combined-modality treatment for early-stage Hodgkin lymphoma, despite its association with increased survival.
RT Fails to Improve on Chemo in Resected Gastric Cancer
Adding radiotherapy to adjuvant chemotherapy in the ARTIST trial yielded similar results to chemo alone in patients with D2 lymph node-resected gastric cancer.
Adding RT to ADT Benefits Older Prostate Cancer Patients
Older men who received radiotherapy in addition to ADT had fewer deaths from their locally advanced prostate cancer compared with those treated with ADT alone.
ACR Appropriateness Criteria® Postradical Prostatectomy Irradiation in Prostate Cancer
The purpose of this article is to present an updated set of American College of Radiology consensus guidelines formed from an expert panel on the appropriate use of radiation therapy in postprostatectomy prostate cancer.
Partial Breast Irradiation Sufficient in Early Disease
Accelerated partial breast irradiation was shown to be just as effective and safe as whole breast irradiation in early-stage breast cancer patients.
SBRT/Erlotinib Yield Big Improvements in Stage IV NSCLC
A small trial yielded “dramatic” results with high progression-free and overall survival using SBRT along with erlotinib for patients with stage IV lung cancer.
By clicking Accept, you agree to become a member of the UBM Medica Community.